Skip to main content
NIH funding notice RFA-CA-21-035

The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed)

Closed on September 9, 2021.

Posted
June 1, 2021
Close date
September 9, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
8
8 new
Median first-year cost
$683,474
$5,537,560 in all
Institutions
8
8 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
  2. BOSTON UNIVERSITY MEDICAL CAMPUS1
  3. EASTERN VIRGINIA MEDICAL SCHOOL1
  4. FRED HUTCHINSON CANCER CENTER1
  5. JOHNS HOPKINS UNIVERSITY1

and 3 other institutions

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 PCRB-D (M1))8
8 awards under RFA-CA-21-035 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2022Biomarkers for optimizing risk prediction and early detection of cancers of the colon and esophagus1U2CCA271902-01Grady, William MalloryYeung, Cecilia CFRED HUTCHINSON CANCER CENTER, WAFirst-year cost $739,072Study section ZCA1
FY2022The Boston University - UCLA Lung Cancer Biomarker Characterization Center1U2CCA271898-01Beane, Jennifer EllenDubinett, Steven M.Hsu, WilliamLenburg, Marc ElliottBOSTON UNIVERSITY MEDICAL CAMPUS, MAFirst-year cost $718,649Study section ZCA1
FY2022High-throughput immunoproteomics for cancer biomarker discovery1U2CCA271903-01Anderson, Karen SueLabaer, JoshuaARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZFirst-year cost $710,300Study section ZCA1
FY2022Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer1U2CCA271871-01Patel, AbhijitSkates, Steven JMASSACHUSETTS GENERAL HOSPITAL, MAFirst-year cost $686,372Study section ZCA1
FY2022Michigan-VUMC Biomarker Characterization Center1U2CCA271854-01Chinnaiyan, Arul MTosoian, Jeffrey JohnUNIVERSITY OF MICHIGAN AT ANN ARBOR, MIFirst-year cost $680,576Study section ZCA1
FY2022A multidisciplinary BCC for ovarian cancer early detection: translating discoveries to clinical use with a by-design approach1U2CCA271891-01Shih, Ie-MingZhang, ZhenJOHNS HOPKINS UNIVERSITY, MDFirst-year cost $679,873Study section ZCA1
FY2022Virginia-UCLA-Toronto Biomarker Characterization Center1U2CCA271894-01Boutros, Paul ChristopherKislinger, ThomasSemmes, Oliver JohnEASTERN VIRGINIA MEDICAL SCHOOL, VAFirst-year cost $664,127Study section ZCA1
FY2022Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies1U2CCA271885-01Herman, James G.Stass, Sanford AWang, Tza-Huei JeffUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PAFirst-year cost $658,591Study section ZCA1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-21-035: The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) | ScienceDex | ConductScience